Insulet Corp.
PODD
Rank in Stocks
#2100
Insulet Corporation develops, manufactures, and sells insulin delivery systems... Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Share Price
$141.05
Market Cap
$9.78B
Change (1 day)
-0.04%
Change (1 year)
-55.73%
Country
US
Trade Insulet Corp. (PODD)
Category
Healthcare
P/B ratio for Insulet Corp. (PODD)
P/B ratio as of October 2026 TTM: 6.53
According to Insulet Corp. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 6.53. At the end of 2023 the company had a P/B ratio of 20.66.
P/B ratio history for Insulet Corp. from 2002 to 2026
P/B ratio at the end of each year
| Year | P/B Ratio | Change |
|---|---|---|
| 2026 (TTM) | 6.53 | -56.78% |
| 2024 | 15.10 | -26.90% |
| 2023 | 20.66 | -51.82% |
| 2022 | 42.87 | 32.40% |
| 2021 | 32.38 | 18.10% |
| 2020 | 27.42 | -79.94% |
| 2019 | 136.68 | 520.91% |
| 2018 | 22.01 | -12.82% |
| 2017 | 25.25 | -25.35% |
| 2016 | 33.82 | -46.36% |
| 2015 | 63.05 | 106.29% |
| 2014 | 30.57 | 90.05% |
| 2013 | 16.08 | -30.14% |
| 2012 | 23.02 | 86.95% |
| 2011 | 12.31 | 32.85% |
| 2010 | 9.27 | 15.42% |
| 2009 | 8.03 | -83.90% |
| 2008 | 49.87 | 1,074.45% |
| 2007 | 4.25 | -3,051.01% |
| 2006 | -0.14 | 95.52% |
| 2005 | -0.07 | -29.23% |
| 2004 | -0.10 | -26.61% |
| 2003 | -0.14 | -44.30% |
| 2002 | -0.25 | 0.00% |
P/B ratio for similar companies or competitors
| Company | P/B Ratio | P/B Ratio Difference | Country |
|---|---|---|---|
| 3.5116 | -46.19% |
US
|
|
| 2.0146 | -69.13% |
IE
|
|
| 4.5025 | -31.01% |
US
|
|
| 2.5486 | -60.95% |
US
|
|
| - | - |
DE
|
